SecFilingDex

Celularity Inc

5 SEC EDGAR filings indexed (CIK 0001752828) across 5 form types.

Filing profile

Celularity Inc (CELU) has 5 SEC filings indexed on SecFilingDex, across 5 form types, from September 28, 2026 to November 10, 2026. The filer is classified under Pharmaceutical Preparations (SIC 2834).

Its most frequent disclosure is the DEF 14A (Proxy statement) with 1 filing — Definitive proxy statement disclosing matters to be voted on by shareholders, including executive compensation. 5 of these filings were disclosed in the twelve months to November 10, 2026. 2 of the 5 are amendments (a corrected or updated version of an earlier filing).

Disclosure mix

  • 1DEF 14AProxy statement · annual (pre-meeting)
  • 1PRE 14ASEC filing
  • 110-K/AAnnual report · annual
  • 110-QQuarterly report · quarterly
  • 1SC 13D/A5%+ activist stake · event-driven (within 10 days)

Profile derived from 5 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.

All filings

Authoritative source

https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1752828&type=&dateb=&owner=include&count=40 ↗

SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.

Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.